Beneficial and deleterious, the dual role of small stress proteins in human diseases: Implications for therapeutic strategies

Small Stress Proteins and Human Diseases

Volumn , Issue , 2011, Pages 457-476

  Simon, Stéphanie ^a   Arrigo, André Patrick ^a  

^a CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895379683     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (157)

1. Horwitz, J., Huang, Q.-L. and Ding, L.-L. (1992). Alpha-crystallin can function as a molecular chaperone. Proc. Natl. Acad. Sci. USA. 89, 10449-10453.
2. Jakob, U., Gaestel, M., Engels, K. and Buchner, J. (1993). Small heat shock proteins are molecular chaperones. J. Biol. Chem. 268, 1517-1520.
3. Ganea, E. (2001). Chaperone-like activity of alpha-crystallin and other small heat shock proteins. Curr Protein Pept Sci. 2, 205-225.
4. Carra, S., Sivilotti, M., Chavez Zobel, A.T., Lambert, H. and Landry, J. (2005). HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells. Hum Mol Genet. 14, 1659-1669.
5. Bellyei, S. et al. (2007). Preventing apoptotic cell death by a novel small heat shock protein. Eur J Cell Biol. 86, 161-171.
6. Markossian, K.A., Yudin, I.K. and Kurganov, B.I. (2009). Mechanism of Suppression of Protein Aggregation by alpha-Crystallin. Int J Mol Sci. 10, 1314-45.
7. Freeman, B.C. and Morimoto, R.I. (1996). The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding. Embo J. 15, 2969-2979.
8. Bukau, B. and Horwich, A.L. (1998). The Hsp70 and Hsp60 chaperone machines. Cell, 92, 351-366.
9. Buchner, J. (1999). Hsp90 & Co.-a holding for folding. Trends Biochem Sci 24, 136-141.
10. Lee, G.J., Roseman, A.M., Saibil, H.R. and Vierling, E. (1997). A small heat shock protein stably binds heat-denatured model substrates and can maintain a substrate in a folding-competent state. EMBO J. 16, 659-671.
11. Ehrnsperger, M., Graber, S., Gaestel, M. and Buchner, J. (1997). Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation. EMBO J. 16, 221-229.
12. Lee, G.J. and Vierling, E. (2000). A small heat shock protein cooperates with heat shock protein 70 systems to reactivate a heat-denatured protein. Plant Physiol. 122, 189-198.
13. Arrigo, A.-P., Suhan, J.P. and Welch, W.J. (1988). Dynamic changes in the structure and intracellular locale of the mammalian low-molecular-weight heat shock protein. Mol. Cell. Biol. 8, 5059-5071.
14. Bryantsev, A.L., Loktionova, S.A., Ilyinskaya, O.P., Tararak, E.M., Kampinga, H.H. and Kabakov, A.E. (2002). Distribution, phosphorylation, and activities of Hsp25 in heat-stressed H9c2 myoblasts: a functional link to cytoprotection. Cell Stress Chaperones 7, 146-155.
15. Bryantsev, A.L. et al. (2007). Regulation of stress-induced intracellular sorting and chaperone function of Hsp27 (HspB1) in mammalian cells. Biochem J. 407, 407-417.
16. Adhikari, A.S., Sridhar Rao, K., Rangaraj, N., Parnaik, V.K. and Mohan Rao, C. (2004). Heat stress-induced localization of small heat shock proteins in mouse myoblasts: intranuclear lamin A/C speckles as target for alphaB-crystallin and Hsp25. Exp Cell Res 299, 393-403.
17. Brunet Simioni, M. et al. (2009). Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity. Oncogene 28, 3332-3344.
18. van den, I.P., Wheelock, R., Prescott, A., Russell, P. and Quinlan, R.A. (2003). Nuclear speckle localisation of the small heat shock protein alpha B-crystallin and its inhibition by the R120G cardiomyopathy-linked mutation. Exp Cell Res. 287, 249-261.
19. Vos, M.J., Kanon, B. and Kampinga, H.H. (2009). HSPB7 is a SC35 speckle resident small heat shock protein. Biochim Biophys Acta, 1793, 1343-1353.
20. Cuesta, R., Laroia, G. and Schneider, R.J. (2000). Chaperone Hsp27 inhibits translation during heat shock by binding eIF4G and facilitating dissociation of cap-initiation complexes. Genes Dev 14, 1460-1470.
21. Nicholl, I.D. and Quinlan, R.A. (1994). Chaperone Activity of alpha-Crystallins Modulates Intermediate Filament Assembly. EMBO J. 13, 945-953.
22. Lavoie, J.N., Hickey, E., Weber, L.A. and Landry, J. (1993). Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of Heat Shock Protein 27. J. Biol. Chem. 268, 24210-24214.
23. Perng, M.D., Cairns, L., van den, I.P., Prescott, A., Hutcheson, A.M. and Quinlan, R.A. (1999). Intermediate filament interactions can be altered by HSP27 and alphaB-crystallin. J Cell Sci. 112, 2099-2112.
24. Parcellier, A. et al. (2006). HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S-phase re-entry in stressed cells. Faseb J 20, 1179-1181.
25. Neckers, L., Mimnaugh, E. and Schulte, T.W. (1999). Hsp90 as an anti-cancer target. Drug Resist Updat. 2, 165-172.
26. Georgakis, G.V. and Younes, A. (2005). Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond. Future Oncol. 1, 273-281.
27. Pandey, P. et al. (2000). Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene 19, 1975-1981.
28. Koteiche, H.A. and McHaourab, H.S. (2003). Mechanism of chaperone function in small heat-shock proteins. Phosphorylation-induced activation of two-mode binding in alphaB-crystallin. J Biol Chem. 278, 10361-10367.
29. Aquilina, J.A., Benesch, J.L., Ding, L.L., Yaron, O., Horwitz, J. and Robinson, C.V. (2004). Phosphorylation of alphaB-crystallin alters chaperone function through loss of dimeric substructure. J Biol Chem. 279, 28675-28680.
30. Rogalla, T. et al. (1999). Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem. 274, 18947-18956.
31. Liang, J.J. and Akhtar, N.J. (2000). Human lens high-molecular-weight alpha-crystallin aggregates. Biochem Biophys Res Commun. 275, 354-359.
32. Horwitz, J., Huang, Q. and Ding, L. (2004). The native oligomeric organization of alpha-crystallin, is it necessary for its chaperone function? Exp Eye Res 79, 817-821.
33. Ahmad, M.F., Raman, B., Ramakrishna, T. and Rao Ch, M. (2008). Effect of phosphorylation on alpha B-crystallin: differences in stability, subunit exchange and chaperone activity of homo and mixed oligomers of alpha B-crystallin and its phosphorylation-mimicking mutant. J Mol Biol. 375, 1040-1051.
34. Garrido, C., Bruey, J.M., Fromentin, A., Hammann, A., Arrigo, A.P. and Solary, E. (1999). HSP27 inhibits cytochrome c-dependent activation of procaspase-9. Faseb J 13, 2061-2070.
35. Bruey, J.M. et al. (2000). Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol. 2, 645-652.
36. Samali, A. et al. (2001). Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones 6, 49-58.
37. Paul, C., Manero, F., Gonin, S., Kretz-Remy, C., Virot, S. and Arrigo, A.P. (2002). Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol. 22, 816-834.
38. Mao, Y.W., Liu, J.P., Xiang, H. and Li, D.W. (2004). Human alphaA-and alphaB-crystallins bind to Bax and Bcl-X(S) to sequester their translocation during staurosporine-induced apoptosis. Cell Death Differ. 11, 512-526.
39. Li, D.W. et al. (2005). Calcium-activated RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by alpha B-crystallin through inhibition of RAS activation. Mol Biol Cell. 16, 4437-4453.
40. Havasi, A., Li, Z., Wang, Z., Martin, J.L., Botla, V., Ruchalski, K., Schwartz, J.H. and Borkan, S.C. (2008). Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. J Biol Chem. 283, 12305-12313.
41. Charette, S.J., Lavoie, J.N., Lambert, H. and Landry, J. (2000). Inhibition of daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol. 20, 7602-7612.
42. Rane, M.J. et al. (2003). Heat shock protein 27 controls apoptosis by regulating akt activation. J Biol Chem 278, 27828-27835.
43. Kamradt, M.C. et al. (2005). The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3. J Biol Chem. 280, 11059-11066.
44. Wu, R., Kausar, H., Johnson, P., Montoya-Durango, D.E., Merchant, M. and Rane, M.J. (2007). Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex. J Biol Chem. 282, 21598-21608.
45. Bruey, J.M., Paul, C., Fromentin, A., Hilpert, S., Arrigo, A.P., Solary, E. and Garrido, C. (2000). Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo. Oncogene 19, 4855-4863.
46. Spector, N.L. et al. (1994). Regulation of the 28kDa heat shock protein by retinoic acid during diferentiation of human leukemic HL-60 cells. FEBS Lett. 337, 184-188.
47. Spector, N.L., Ryan, C., Samson, W., Levine, H., Nadler, L.M. and Arrigo, A.-P. (1993). Heat shock protein is a unique marker of growth arrest during macrophage differenciation of HL-60 cells. J Cell Physiol 156, 619-625.
48. Chaufour, S., Mehlen, P. and Arrigo, A.P. (1996). Transient accumulation, phosphorylation and changes In the oligomerization of Hsp27 during retinoic acid-induced differentiation of HL-60 cells: Possible role in the control of cellular growth and differentiation. Cell Stress Chaperones, 1, 225-235.
49. Mehlen, P., Mehlen, A., Godet, J. and Arrigo, A.-P. (1997). hsp27 as a Switch between Differentiation and Apoptosis in Murine Embryonic Stem Cells. J. Biol Chem 272, 31657-31665.
50. Mehlen, P., Coronas, V., Ljubic-Thibal, V., Ducasse, C., Granger, L., Jourdan, F. and Arrigo, A.P. (1999). Small stress protein Hsp27 accumulation during dopamine-mediated differentiation of rat olfactory neurons counteracts apoptosis. Cell Death Differ. 6, 227-233.
51. Davidson, S.M. and Morange, M. (2000). Hsp25 and the p38 MAPK pathway are involved in differentiation of cardiomyocytes. Dev Biol 218, 146-160.
52. Arrigo, A.P. and Ducasse, C. (2002). Expression of the anti-apoptotic protein Hsp27 during both the keratinocyte differentiation and dedifferentiation of HaCat cells: expression linked to changes in intracellular protein organization? Exp Gerontol. 37, 1247-1255.
53. Duverger, O., Paslaru, L. and Morange, M. (2004). HSP25 is involved in two steps of the differentiation of PAM212 keratinocytes. J Biol Chem. 279, 10252-10260.
54. Arrigo, A.P. (2005). In search of the molecular mechanism by which small stress proteins counteract apoptosis during cellular differentiation. J Cell Biochem. 94, 241-246.
55. Brown, D.D., Christine, K.S., Showell, C. and Conlon, F.L. (2007). Small heat shock protein Hsp27 is required for proper heart tube formation. Genesis, 45, 667-678.
56. Kamradt, M.C., Chen, F., Sam, S. and Cryns, V.L. (2002). The small heat shock protein alpha B-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation. J Biol Chem 277, 38731-38736.
57. Ikeda, R. et al. (2006). The small heat shock protein alphaB-crystallin inhibits differentiation-induced caspase 3 activation and myogenic differentiation. Biol Pharm Bull. 29, 1815-1819.
58. Liu, J.P. et al. (2004). Human alphaA-and alphaB-crystallins prevent UVA-induced apoptosis through regulation of PKCalpha, RAF/MEK/ERK and AKT signaling pathways. Exp Eye Res. 79, 393-403.
59. Boelens, W.C., Croes, Y. and de Jong, W.W. (2001). Interaction between alphaB-crystallin and the human 20S proteasomal subunit C8/alpha7. Biochim Biophys Acta, 1544, 311-319.
60. Parcellier, A. et al. (2003). HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol 23, 5790-5802.
61. den Engelsman, J., Keijsers, V., de Jong, W.W. and Boelens, W.C. (2003). The small heat-shock protein alpha B-crystallin promotes FBX4-dependent ubiquitination. J Biol Chem. 278, 4699-4704.
62. Barbash, O., Lin, D.I. and Diehl, J.A. (2007). SCF Fbx4/alphaB-crystallin cyclin D1 ubiquitin ligase: a license to destroy. Cell Div. 2, 2.
63. McDonough, H. and Patterson, C. (2003). CHIP: a link between the chaperone and proteasome systems. Cell Stress Chaperones 8, 303-308.
64. Keller, J.N., Dimayuga, E., Chen, Q., Thorpe, J., Gee, J. and Ding, Q. (2004). Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol. 36, 2376-2391.
65. Kiffin, R., Bandyopadhyay, U. and Cuervo, A.M. (2006). Oxidative stress and autophagy. Antioxid Redox Signal. 8, 152-162.
66. Nivon, M., Richet, E., Codogno, P., Arrigo, A.P. and Kretz-Remy, C. (2009). Autophagy activation by NFkappaB is essential for cell survival after heat shock. Autophagy 5, 766-783.
67. Carra, S., Seguin, S.J. and Landry, J. (2008). HspB8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy. Autophagy 4, 237-239.
68. Carra, S. (2009). The stress-inducible HspB8-Bag3 complex induces the eIF2alpha kinase pathway: implications for protein quality control and viral factory degradation? Autophagy. 5, 428-429.
69. Landry, J., Chretien, P., Lambert, H., Hickey, E. and Weber, L.A. (1989). Heat shock resistance confered by expression of the human HSP 27 gene in rodent cells. J. Cell Biol. 109, 7-15.
70. Aoyama, A., Frohli, E., Schafer, R. and Klemenz, R. (1993). Alpha B-crystallin expression in mouse NIH 3T3 fibroblasts: glucocorticoid responsiveness and involvement in thermal protection. Mol Cell Biol. 13, 1824-1835.
71. Mehlen, P., Préville, X., Chareyron, P., Briolay, J., Klemenz, R. and Arrigo, A.-P. (1995). Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF-and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J Immunol 154, 363-374.
72. Preville, X., Salvemini, F., Giraud, S., Chaufour, S., Paul, C., Stepien, G., Ursini, M.V. and Arrigo, A.P. (1999). Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp Cell Res. 247, 61-78.
73. Arrigo, A.P. (2001). Hsp27: novel regulator of intracellular redox state. IUBMB Life 52, 303-307.
74. Wyttenbach, A., Sauvageot, O., Carmichael, J., Diaz-Latoud, C., Arrigo, A.P. and Rubinsztein, D.C. (2002). Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum Mol Genet 11, 1137-1151.
75. Firdaus, W.J., Wyttenbach, A., Diaz-Latoud, C., Currie, R.W. and Arrigo, A.P. (2006). Analysis of oxidative events induced by expanded polyglutamine huntingtin exon 1 that are differentially restored by expression of heat shock proteins or treatment with an antioxidant. Febs J. 273, 3076-3093.
76. Outeiro, T.F., Klucken, J., Strathearn, K.E., Liu, F., Nguyen, P., Rochet, J.C., Hyman, B.T. and McLean, P.J. (2006). Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation. Biochem Biophys Res Commun. 351, 631-638.
77. Lee, S., Carson, K., Rice-Ficht, A. and Good, T. (2006). Small heat shock proteins differentially affect Abeta aggregation and toxicity. Biochem Biophys Res Commun. 347, 527-533.
78. Perrin, V., Regulier, E., Abbas-Terki, T., Hassig, R., Brouillet, E., Aebischer, P., Luthi-Carter, R. and Deglon, N. (2007). Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease. Mol Ther 15, 903-911.
79. Wilhelmus, M.M., Boelens, W.C., Otte-Holler, I., Kamps, B., Kusters, B., Maat-Schieman, M.L., de Waal, R.M. and Verbeek, M.M. (2006). Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity. Acta Neuropathol. 111, 139-149.
80. Andley, U.P. (2007). Crystallins in the eye: Function and pathology. Prog Retin Eye Res. 26, 78-98.
81. Renkawek, K., Bosman, G.J. and de Jong, W.W. (1994). Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia. Acta Neuropathol. (Berl) 87, 511-519.
82. Muchowski, P.J. (2002). Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones? Neuron, 35, 9-12.
83. Wyttenbach, A. (2004). Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis. J Mol Neurosci. 23, 69-96.
84. Muchowski, P.J. and Wacker, J.L. (2005). Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci. 6, 11-22.
85. Vicart, P. et al. (1998). A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 20, 92-95.
86. Elicker, K.S. and Hutson, L.D. (2007). Genome-wide analysis and expression profiling of the small heat shock proteins in zebrafish. Gene, 403, 60-69.
87. Halliwell, B. (2001). Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging, 18, 685-716.
88. Bharath, S., Hsu, M., Kaur, D., Rajagopalan, S. and Andersen, J.K. (2002). Glutathione, iron and Parkinson's disease. Biochem Pharmacol. 64, 1037-1048.
89. Jenner, P. and Olanow, C.W. (1996). Oxidative stress and the pathogenesis of Parkinson's disease. Neurology, 47, S161-S170.
90. Browne, S.E., Ferrante, R.J. and Beal, M.F. (1999). Oxidative stress in Huntington's disease. Brain Pathol 9, 147-163.
91. Tabner, B.J., Turnbull, S., El-Agnaf, O. and Allsop, D. (2001). Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr Top Med Chem. 1, 507-517.
92. Turnbull, S., Tabner, B.J., Brown, D.R. and Allsop, D. (2003). Copper-dependent generation of hydrogen peroxide from the toxic prion protein fragment PrP106-126. Neurosci Lett. 336, 159-162.
93. Choi, J., Rees, H.D., Weintraub, S.T., Levey, A.I., Chin, L.S. and Li, L. (2005). Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem. 280, 11648-11655.
94. Firdaus, W.J., Wyttenbach, A., Giuliano, P., Kretz-Remy, C., Currie, R.W. and Arrigo, A.P. (2006). Huntingtin inclusion bodies are iron-dependent centers of oxidative events. Febs J. 273, 5428-5441.
95. Fox, J.H. et al. (2007). Mechanisms of copper ion mediated Huntington's disease progression. PLoS ONE, 2, e334.
96. Janue, A., Olive, M. and Ferrer, I. (2007). Oxidative stress in desminopathies and myotilinopathies: a link between oxidative damage and abnormal protein aggregation. Brain Pathol. 17, 377-388.
97. Liu, J., Chen, Q., Huang, W., Horak, K.M., Zheng, H., Mestril, R. and Wang, X. (2006). Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. Faseb J. 20, 362-364.
98. Hilditch-Maguire, P., Trettel, F., Passani, L.A., Auerbach, A., Persichetti, F. and MacDonald, M.E. (2000). Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet. 9, 2789-2797.
99. Huang, X., Moir, R.D., Tanzi, R.E., Bush, A.I. and Rogers, J.T. (2004). Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann N Y Acad Sci. 1012, 153-163.
100. Halliwell, B. and Gutteridge, J. (1984). Role of iron in oxygen radical reactions. Methods Enzymol. 105, 47-56.
101. Sayre, L.M., Perry, G., Atwood, C.S. and Smith, M.A. (2000). The role of metals in neurodegenerative diseases. Cell Mol Biol (Noisy-le-grand) 46, 731-741.
102. Shoham, S. and Youdim, M.B. (2000). Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases. Cell Mol Biol (Noisy-le-grand) 46, 743-760.
103. Mehlen, P., Préville, X., Kretz-Remy, C. and Arrigo, A.-P. (1996). Human hsp27, Drosophila hsp27 and human αB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these protein against TNF-induced cell death. EMBO J 15, 2695-2706.
104. Arrigo, A.P. (1998). Small stress proteins: chaperones that act as regulators of intracellular redox state and programmed cell death. Biol Chem 379, 19-26.
105. Arrigo, A.P., Virot, S., Chaufour, S., Firdaus, W., Kretz-Remy, C. and Diaz-Latoud, C. (2005). Hsp27 consolidates intracellular redox homeostasis by upholding glutathione in its reduced form and by decreasing iron intracellular levels. Antioxid Redox Signal, 7, 414-422.
106. Chen, H., Zheng, C., Zhang, Y., Chang, Y.Z., Qian, Z.M. and Shen, X. (2006). Heat shock protein 27 downregulates the transferrin receptor 1-mediated iron uptake. Int J Biochem Cell Biol. 38, 1402-1416.
107. Kammanadiminti, S.J. and Chadee, K. (2006). Suppression of NF-kappaB activation by Entamoeba histolytica in intestinal epithelial cells is mediated by heat shock protein 27. J Biol Chem. 281, 26112-26120.
108. Alford, K.A., Glennie, S., Turrell, B.R., Rawlinson, L., Saklatvala, J. and Dean, J.L. (2007). HSP27 functions in inflammatory gene expression and TAK1-mediated signalling. J Biol Chem. 282, 6232-6241.
109. Dodd, S.L., Hain, B., Senf, S.M. and Judge, A.R. (2009). Hsp27 inhibits IKK{beta}-induced NF-{kappa}B activity and skeletal muscle atrophy. Faseb J. 23, 3415-3425.
110. Merendino, A.M. et al. (2002). Heat shock protein-27 protects human bronchial epithelial cells against oxidative stress-mediated apoptosis: possible implication in asthma. Cell Stress Chaperones, 7, 269-280.
111. Dillmann, W.H. (1999). Heat shock proteins and protection against ischemic injury. Infect Dis Obstet Gynecol. 7, 55-57.
112. Efthymiou, C.A., Mocanu, M.M., de Belleroche, J., Wells, D.J., Latchmann, D.S. and Yellon, D.M. (2004). Heat shock protein 27 protects the heart against myocardial infarction. Basic Res Cardiol. 99, 392-394.
113. Eaton, P., Awad, W.I., Miller, J.I., Hearse, D.J. and Shattock, M.J. (2000). Ischemic preconditioning: a potential role for constitutive low molecular weight stress protein translocation and phosphorylation? J Mol Cell Cardiol. 32, 961-971.
114. Lewis, S.E. et al. (1999). A role for HSP27 in sensory neuron survival. J Neurosci 19, 8945-8953.
115. Agius, M.A., Kirvan, C.A., Schafer, A.L., Gudipati, E. and Zhu, S. (1999). High prevalence of anti-alpha-crystallin antibodies in multiple sclerosis: correlation with severity and activity of disease. Acta Neurol Scand. 100, 139-147.
116. Tezel, G. and Wax, M.B. (2000). The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells. J Neurosci. 20, 3552-3562.
117. Ciocca, D.R. and Calderwood, S.K. (2005). Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones, 10, 86-103.
118. Calderwood, S.K., Khaleque, M.A., Sawyer, D.B. and Ciocca, D.R. (2006). Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci. 31, 164-172.
119. Mehlen, P., Schulze-Osthoff, K. and Arrigo, A.P. (1996). Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1-and staurosporine-induced cell death. The Journal of Biological Chemistry, 271, 16510-16514.
120. Richards, E.H., Hickey, E., Weber, L.A. and Master, J.R. (1996). Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells. Cancer Res. 56, 2446-2451.
121. Arrigo, A.P. (2000). sHsp as novel regulators of programmed cell death and tumorigenicity. Pathol Biol. (Paris) 48, 280-288.
122. Garrido, C., Gurbuxani, S., Ravagnan, L. and Kroemer, G. (2001). Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun. 286, 433-442.
123. Kase, S., Parikh, J.G. and Rao, N.A. (2009). Expression of heat shock protein 27 and alpha-crystallins in human retinoblastoma after chemoreduction. Br J Ophthalmol 93, 541-544.
124. Hitotsumatsu, T., Iwaki, T., Fukui, M. and Tateishi, J. (1996). Distinctive immunohistochemical profiles of small heat shock proteins (heat shock protein 27 and alpha B-crystallin) in human brain tumors. Cancer, 77, 352-361.
125. Mineva, I. et al. (2005). Differential expression of alphaB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific alphaB-crystallin gene (CRYAB) silencing. Cell Stress Chaperones, 10, 171-184.
126. Mehlen, P. and Arrigo, A.-P. (1994). The serum-induced phosphorylation of mammalian hsp27 correlates with changes in its intracellular localization and levels of oligomerization. Eur J Biochem 221, 327-334.
127. Tsvetkova, N.M. et al. (2002). Small heat-shock proteins regulate membrane lipid polymorphism. Proc Natl Acad Sci U S A. 99, 13504-13509.
128. Chowdary, T.K., Bakthisaran, R., Tangirala, R. and Rao, M.C. (2006). Interaction of mammalian Hsp22 with lipid membranes. Biochem J. 401, 437-445.
129. Basu, S. and Srivastava, P.K. (2000). Heat shock proteins: the fountainhead of innate and adaptive immune responses. Cell Stress Chaperones, 5, 443-451.
130. Wells, A.D. and Malkovsky, M. (2000). Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. Immunol Today. 21, 129-132.
131. Pinz, I., Robbins, J., Rajasekaran, N.S., Benjamin, I.J. and Ingwall, J.S. (2008). Unmasking different mechanical and energetic roles for the small heat shock proteins CryAB and HSPB2 using genetically modified mouse hearts. Faseb J. 22, 84-92.
132. Zantema, A., Vries, M.V.-D., Maasdam, D., Bol, S. and Eb, A.v.d. (1992). Heat shock protein 27 and αB-cristallin can form a complex, which dissociates by heat shock. J. Biol. Chem. 267, 12936-12941.
133. Sun, T.X. and Liang, J.J. (1998). Intermolecular exchange and stabilization of recombinant human alphaA-and alphaB-crystallin. J Biol Chem 273, 286-290.
134. Saha, S. and Das, K.P. (2004). Relationship between chaperone activity and oligomeric size of recombinant human alphaA-and alphaB-crystallin: a tryptic digestion study. Proteins, 57, 610-7.
135. Bukach, O.V., Glukhova, A.E., Seit-Nebi, A.S. and Gusev, N.B. (2009). Heterooligomeric complexes formed by human small heat shock proteins HspB1 (Hsp27) and HspB6 (Hsp20). Biochim Biophys Acta, 1794, 486-495.
136. Sun, X., Welsh, M.J. and Benndorf, R. (2006). Conformational changes resulting from pseudophosphorylation of mammalian small heat shock proteins--a two-hybrid study. Cell Stress Chaperones, 11, 61-70.
137. Simon, S., Fontaine, J.M., Martin, J.L., Sun, X., Hoppe, A.D., Welsh, M.J., Benndorf, R. and Vicart, P. (2007). Myopathy-associated alpha B-crystallin mutants: Abnormal phosphorylation, intracellular location, and interactions with other small heat shock proteins. J Biol Chem. 82, 34276-34287.
138. Michiel, M., Skouri-Panet, F., Duprat, E., Simon, S., Ferard, C., Tardieu, A. and Finet, S. (2009). Abnormal assemblies and subunit exchange of alphaB-crystallin R120 mutants could be associated with destabilization of the dimeric substructure. Biochemistry 48, 442-453.
139. Fu, L. and Liang, J.J. (2003). Alteration of protein-protein interactions of congenital cataract crystallin mutants. Invest Ophthalmol Vis Sci. 44, 1155-1159.
140. Fontaine, J.M., Sun, X., Hoppe, A.D., Simon, S., Vicart, P., Welsh, M.J. and Benndorf, R. (2006). Abnormal small heat shock protein interactions involving neuropathy-associated HSP22 (HSPB8) mutants. Faseb J 25, 25.
141. Laudanski, K., De, A. and Miller-Graziano, C. (2007). Exogenous heat shock protein 27 uniquely blocks differentiation of monocytes to dendritic cells. Eur J Immunol 37, 2812-2824.
142. Rayner, K., Chen, Y.X., McNulty, M., Simard, T., Zhao, X., Wells, D.J., de Belleroche, J. and O'Brien, E.R. (2008). Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-A. Circ Res. 103, 133-141.
143. Sanbe, A. et al. (2009). Protective effect of geranylgeranylacetone via enhancement of HSPB8 induction in desmin-related cardiomyopathy. PLoS One 4, e5351.
144. Nedellec, P., Edling, Y., Perret, E., Fardeau, M. and Vicart, P. (2002). Glucocorticoid treatment induces expression of small heat shock proteins in human satellite cell populations: consequences for a desmin-related myopathy involving the R120G alpha B-crystallin mutation. Neuromuscul Disord. 12, 457-465.
145. Maloyan, A., Gulick, J., Glabe, C.G., Kayed, R. and Robbins, J. (2007). Exercise reverses preamyloid oligomer and prolongs survival in alphaB-crystallin-based desmin-related cardiomyopathy. Proc Natl Acad Sci U S A. 104, 5995-6000.
146. Gidalevitz, T., Ben-Zvi, A., Ho, K.H., Brignull, H.R. and Morimoto, R.I. (2006). Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311, 1471-1474.
147. Aloy, M.T., Hadchity, E., Bionda, C., Diaz-Latoud, C., Claude, L., Rousson, R., Arrigo, A.P. and Rodriguez-Lafrasse, C. (2007). Protective Role of Hsp27 Protein Against Gamma Radiation-Induced Apoptosis and Radiosensitization Effects of Hsp27 Gene Silencing in Different Human Tumor Cells. Int J Radiat Oncol Biol Phys. 70, 543-553.
148. Rocchi, P., Jugpal, P., So, A., Sinneman, S., Ettinger, S., Fazli, L., Nelson, C. and Gleave, M. (2006). Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro. BJU Int. 28, 28.
149. Bausero, M.A. et al. (2006). Silencing the hsp25 gene eliminates migration capability of the highly metastatic murine 4T1 breast adenocarcinoma cell. Tumour Biol. 27, 17-26.
150. Kamada, M., So, A., Muramaki, M., Rocchi, P., Beraldi, E. and Gleave, M. (2007). Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells. Mol Cancer Ther. 6, 299-308.
151. Kumar, P.A. and Reddy, G.B. (2009). Modulation of alpha-crystallin chaperone activity: a target to prevent or delay cataract? IUBMB Life, 61, 485-95.
152. Stacchiotti, A., Bonomini, F., Lavazza, A., Rodella, L.F. and Rezzani, R. (2009). Adverse effects of Cyclosporine A on HSP25, alpha B-crystallin and myofibrillar cytoskeleton in rat heart. Toxicology. 262, 192-198.
153. Babizhayev, M.A. (2009). Current Ocular Drug Delivery Challenges for N-acetylcarnosine: Novel Patented Routes and Modes of Delivery, Design for Enhancement of Therapeutic Activity and Drug Delivery Relationships. Recent Pat Drug Deliv Formul 3, 229-265.
154. Babizhayev, M.A., Burke, L., Micans, P. and Richer, S.P. (2009). N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: Glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population. Clin Interv Aging, 4, 31-50.
155. McCollum, A.K., Teneyck, C.J., Sauer, B.M., Toft, D.O. and Erlichman, C. (2006). Up-regulation of Heat Shock Protein 27 Induces Resistance to 17-Allylamino-Demethoxygeldanamycin through a Glutathione-Mediated Mechanism. Cancer Res. 66, 10967-10975.
156. Paul, C., Simon, S., Gibert, B., Virot, S., Manero, F. and Arrigo, A.-P. (2010). Dynamic processes that reflect anti-apoptotic strategies set up by Hsp27. Exp. Cell Res. Epub. Ahead of print. March 15.
157. Bagneris, C., Bateman, O.A., Naylor, C.E., Cronin, N., Boelens, W.C., Keep, N.H. and Slingsby, C. (2009). Crystal Structures of alpha-Crystallin Domain Dimers of alphaB-Crystallin and Hsp20. J Mol Biol. 392, 1242-1252; Erratum: J. Mol. Biol. 2009, 394, 588.